Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma

标题
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 27, Issue 5, Pages 740-745
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2008-12-30
DOI
10.1200/jco.2008.16.3055

向作者/读者发起求助以获取更多资源

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started